首页> 外文OA文献 >PDB97 IMPACT TO DIABETES QUALITY PERFORMANCE MEASURES IN AN OLDER ADULT POPULATION WHEN USING A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE FOR BASAL-BOLUS INSULIN THERAPY

【2h】

PDB97 IMPACT TO DIABETES QUALITY PERFORMANCE MEASURES IN AN OLDER ADULT POPULATION WHEN USING A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE FOR BASAL-BOLUS INSULIN THERAPY

机译：使用24小时穿戴胰岛素递送装置的基础推注胰岛素治疗时，PDB97对糖尿病患者对糖尿病质量绩效措施的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
T. Zeidan; C. Nikkel; B. Dziengelewski;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen [J] . Bergenstal Richard M., Peyrot Mark, Dreon Darlene M., Diabetes technology & therapeutics . 2019,第5期

机译：在2型糖尿病中的基础推注疗法的实施：使用胰岛素贴片的胰岛素贴剂进行随机对照试验比较推注胰岛素递送
2. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes [J] . K. Hermansen, P. Fontaine, K. K. Kukolja, Diabetologia . 2004,第4期

机译：1型糖尿病患者基础推注治疗中胰岛素类似物（地特胰岛素和门冬胰岛素）与传统人胰岛素（NPH胰岛素和普通人胰岛素）的比较
3. Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial [J] . Jia Weiping, Xiao Xinhua, Ji Qiuhe, The lancet. Diabetes & endocrinology. . 2015,第4期

机译：东亚2型糖尿病患者每日两次三次预混胰岛素（赖脯胰岛素预混物）与基底推注（甘精胰岛素每天一次加三餐膳食赖脯胰岛素）的比较，每日两次预混胰岛素不能充分控制：标签，随机，对照试验
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Evaluating Hypoglycemic Risk of Two Basal Insulin Delivery Methods for Type 1 Diabetes: A Comparison of Tresiba Insulin Against Continuous Subcutaneous Insulin Infusion Using Data from Continuous Glucose Monitors [D] . Lane, Benjamin. 2020

机译：评估1型糖尿病两种基础胰岛素递送方法的低血糖风险：使用来自连续葡萄糖监测器的数据进行TRESIBA胰岛素对连续皮下胰岛素输注的比较
6. OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes [O] . Pablo Mora, David R Sutton, Ashwini Gore, 2020

机译：OR30-02常规人胰岛素和U100在2型糖尿病中携带24小时可佩戴胰岛素递送装置的U100常规人胰岛素和U100快速作用胰岛素的疗效和安全比较
7. Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis [O] . Trisha Zeidan, Carla Nikkel, Beth Dziengelewski, 2020

机译：型糖尿病患者V-Go®可穿戴胰岛素递送装置提供的基底血管疗法的临床评价：回顾性分析

PDB97 IMPACT TO DIABETES QUALITY PERFORMANCE MEASURES IN AN OLDER ADULT POPULATION WHEN USING A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE FOR BASAL-BOLUS INSULIN THERAPY

著录项

相似文献

相关主题

期刊订阅